WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2008099186) HETEROCYCLIC DERIVATIVES AS M3 MUSCARINIC RECEPTORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2008/099186    International Application No.:    PCT/GB2008/000519
Publication Date: 21.08.2008 International Filing Date: 14.02.2008
IPC:
C07D 471/08 (2006.01), A61K 31/439 (2006.01), A61P 11/00 (2006.01), A61P 9/00 (2006.01), A61P 1/00 (2006.01)
Applicants: ARGENTA DISCOVERY LIMITED [GB/GB]; 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex CM19 5TR (GB) (For All Designated States Except US).
AVITABILE, Barbara, Giuseppina [IT/GB]; (GB) (For US Only).
FINCH, Harry [GB/GB]; (GB) (For US Only).
KNIGHT, Jamie, David [GB/GB]; (GB) (For US Only).
NADIN, Alan, John [GB/GB]; (GB) (For US Only).
RAY, Nicholas, Charles [GB/GB]; (GB) (For US Only)
Inventors: AVITABILE, Barbara, Giuseppina; (GB).
FINCH, Harry; (GB).
KNIGHT, Jamie, David; (GB).
NADIN, Alan, John; (GB).
RAY, Nicholas, Charles; (GB)
Agent: STANSFIELD, Kevin; AstraZeneca AB, AstraZeneca Intellectual Property, S-151 85 Södertälje (SE)
Priority Data:
0702994.5 15.02.2007 GB
0722678.0 19.11.2007 GB
Title (EN) HETEROCYCLIC DERIVATIVES AS M3 MUSCARINIC RECEPTORS
(FR) DÉRIVÉS HÉTÉROCYCLIQUES EN TANT QUE RÉCEPTEURS MUSCARINIQUES M3
Abstract: front page image
(EN)This invention relates to M3 antagonists of formula (I) wherein R2, R4, R5, R6, W, V, A, D, X, t, u and v are as defined herein; pharmaceutical compositions containing them; methods for their preparation; and their use in the treatment of diseases where enhanced M3 receptor activation is implicated.
(FR)Cette invention porte sur des antagonistes M3 de formule (I) dans laquelle R2, R4, R5, R6, W, V, A, D, X, t, u et v sont tels que définis présentement ; sur des compositions pharmaceutiques les contenant ; sur des procédés pour leur préparation ; et sur leur utilisation dans le traitement de maladies où une activation accrue du récepteur M3 est impliquée.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)